4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-09-038158
Director sold 5,000 shares at an average $3.51 ($17,525)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GREGG VALETA A · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2009-07-27 | Exercise or conversion : show line 1 in the form | +5,000 | $0.34 | $1,700 | 5,000 | D |
| 2009-07-27 | Sale : show line 2 in the form | −3,500 | $3.50 | $12,250 | 1,500 | D |
| 2009-07-27 | Sale : show line 3 in the form | −1,000 | $3.52 | $3,520 | 500 | D |
| 2009-07-27 | Sale : show line 4 in the form | −500 | $3.51 | $1,755 | 0 | D |
| Open-market sales · 5,000 sh · avg $3.51 · $17,525 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2009-07-27 | Exercise or conversion : show line 5 in the form Option to Purchase Common Shares | −5,000 | $0.34 | $1,700 | $0.34 | 2011-03-27 | 5,000 | 0 | D |
Loading xslF345X03/doc4.xml…